Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
The human monoclonal antibody could be the treatment polymyalgia rheumatica patients experiencing relapses during glucocorticoid tapering have been waiting for.
Internal Medicine October 11th 2023
Rheumatology & Arthritis Learning Network
New research indicates that in axSpA patients, disease activity and physical function are more critical to global functioning than structural damage or spinal mobility. A shift in treatment focus may be necessary for optimal patient care.
Rheumatology October 4th 2023
Rheumatology Advisor
Understanding the role of antidrug antibodies in RA treatment can significantly impact patient management. Stay updated on how these antibodies correlate with bDMARD effectiveness to optimize your treatment plans.
Epoch Health
Understanding the MTHFR gene mutation can significantly impact patient care, especially when prescribing folic acid supplements or fortified foods. Learn how this mutation affects folate metabolism and the increased risks for various health conditions.
Cardiology October 2nd 2023
Healthgrades for Professionals
Persistent fatigue is more than just feeling tired; it can be a symptom of various underlying medical conditions. Understanding the potential causes is crucial for effective patient diagnosis and treatment.
Allergy & Immunology September 7th 2023
Annals of Internal Medicine
This pooled analysis provides robust evidence that low-dose glucocorticoids in RA treatment result in modest weight gain but do not elevate blood pressure. Consider these findings in your risk-benefit discussions with patients.
Clinical Pharmacology August 31st 2023